Allkem downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Rahul Anand downgraded Allkem to Underweight from Equal Weight with a price target of A$12.40, down from A$15.85. Despite good volume growth and quality assets, he sees ramp-up delay potential at Stage 2 and added supply leading to lower prices, the analyst tells investors.